The influence of hypertension on the progression of persistent microalbuminuria in type II diabetes has not yet been clarified. We have studied the effects of 36 months of indapamide treatment (2.5 mg once daily) on blood pressure (BP), albumin excretion rate (AER), urinary immunoglobulin G4 (IgG4), and glomerular filtration rate (GFR) in 10 patients who were mildly hypertensive and had type II microalbuminuric diabetes (AER greater than 30 mg/24 hours and less than 300 mg/24 hours). BP, AER, and IgG4 significantly decreased after 6 months until the end of the study. Mean GFR was 94.4 ± 7.5 ml/min/1.73 m2 in the baseline and did not change significantly throughout the course of the antihypertensive therapy. AER and IgG4 were directly related (r = 0.57; p < 0.004), whereas BP did not relate to GFR, AER, or IgG4. The nephropathy index (45.5 ± 4 in the baseline) significantly decreased at 12 months (38.7 ± 2.1), 24 months (35.4 ± 1.6), and 36 months (36.5 ± 1.5) (at least p < 0.01). Long-term indapamide treatment reduced BP and urinary protein loss without affecting GFR. These results indicate a potential role of this drug in the long-term renal protection of patients with type II diabetes, mild hypertension, and microalbuminuria

Gambardella, S., Frontoni, S., Lala, A., Felici, M., Spallone, V., Scoppola, A., et al. (1991). Regression of microalbuminuria in type II diabetic,hypertensive patients after long-term indapamide treatment. AMERICAN HEART JOURNAL, 122(4 Pt2), 1232-1238.

Regression of microalbuminuria in type II diabetic,hypertensive patients after long-term indapamide treatment

GAMBARDELLA, SERGIO;FRONTONI, SIMONA;LALA, ALBERTO;SPALLONE, VINCENZA;JACOANGELI, FABRIZIO;MENZINGER DI PREUSSENTHAL, GUIDO ENRICO
1991-10-01

Abstract

The influence of hypertension on the progression of persistent microalbuminuria in type II diabetes has not yet been clarified. We have studied the effects of 36 months of indapamide treatment (2.5 mg once daily) on blood pressure (BP), albumin excretion rate (AER), urinary immunoglobulin G4 (IgG4), and glomerular filtration rate (GFR) in 10 patients who were mildly hypertensive and had type II microalbuminuric diabetes (AER greater than 30 mg/24 hours and less than 300 mg/24 hours). BP, AER, and IgG4 significantly decreased after 6 months until the end of the study. Mean GFR was 94.4 ± 7.5 ml/min/1.73 m2 in the baseline and did not change significantly throughout the course of the antihypertensive therapy. AER and IgG4 were directly related (r = 0.57; p < 0.004), whereas BP did not relate to GFR, AER, or IgG4. The nephropathy index (45.5 ± 4 in the baseline) significantly decreased at 12 months (38.7 ± 2.1), 24 months (35.4 ± 1.6), and 36 months (36.5 ± 1.5) (at least p < 0.01). Long-term indapamide treatment reduced BP and urinary protein loss without affecting GFR. These results indicate a potential role of this drug in the long-term renal protection of patients with type II diabetes, mild hypertension, and microalbuminuria
ott-1991
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/13 - ENDOCRINOLOGIA
English
Con Impact Factor ISI
diabetes mellitus; hypertension; kidney function; microalbuminuria; oral drug administration
Gambardella, S., Frontoni, S., Lala, A., Felici, M., Spallone, V., Scoppola, A., et al. (1991). Regression of microalbuminuria in type II diabetic,hypertensive patients after long-term indapamide treatment. AMERICAN HEART JOURNAL, 122(4 Pt2), 1232-1238.
Gambardella, S; Frontoni, S; Lala, A; Felici, M; Spallone, V; Scoppola, A; Jacoangeli, F; MENZINGER DI PREUSSENTHAL, Ge
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/95211
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 30
social impact